273 related articles for article (PubMed ID: 37341194)
1. Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study.
Almansour H; Schick F; Nachbar M; Afat S; Fritz V; Thorwarth D; Zips D; Bertram F; Müller AC; Nikolaou K; Othman AE; Wegener D
Radiol Oncol; 2023 Jun; 57(2):184-190. PubMed ID: 37341194
[TBL] [Abstract][Full Text] [Related]
2. Prospective Image Quality and Lesion Assessment in the Setting of MR-Guided Radiation Therapy of Prostate Cancer on an MR-Linac at 1.5 T: A Comparison to a Standard 3 T MRI.
Almansour H; Afat S; Fritz V; Schick F; Nachbar M; Thorwarth D; Zips D; Müller AC; Nikolaou K; Othman AE; Wegener D
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33810410
[TBL] [Abstract][Full Text] [Related]
3. Prostate diffusion-weighted imaging (DWI) in MR-guided radiotherapy: Reproducibility assessment on 1.5 T MR-Linac and 1.5 T MR-simulator.
Wong OL; Yuan J; Poon DMC; Chiu ST; Yang B; Chiu G; Yu SK; Cheung KY
Magn Reson Imaging; 2024 Mar; 111():47-56. PubMed ID: 38513789
[TBL] [Abstract][Full Text] [Related]
4. Reproducibility of diffusion-weighted magnetic resonance imaging in head and neck cancer assessed on a 1.5 T MR-Linac and comparison to parallel measurements on a 3 T diagnostic scanner.
Habrich J; Boeke S; Fritz V; Koerner E; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
Radiother Oncol; 2024 Feb; 191():110046. PubMed ID: 38070687
[TBL] [Abstract][Full Text] [Related]
5. Reliability of MRI radiomics features in MR-guided radiotherapy for prostate cancer: Repeatability, reproducibility, and within-subject agreement.
Xue C; Yuan J; Poon DM; Zhou Y; Yang B; Yu SK; Cheung YK
Med Phys; 2021 Nov; 48(11):6976-6986. PubMed ID: 34562286
[TBL] [Abstract][Full Text] [Related]
6. Early changes in apparent diffusion coefficient from diffusion-weighted MR imaging during radiotherapy for prostate cancer.
Park SY; Kim CK; Park BK; Park W; Park HC; Han DH; Kim B
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):749-55. PubMed ID: 22154286
[TBL] [Abstract][Full Text] [Related]
7. Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.
Song I; Kim CK; Park BK; Park W
AJR Am J Roentgenol; 2010 Jun; 194(6):W477-82. PubMed ID: 20489065
[TBL] [Abstract][Full Text] [Related]
8. Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients.
Lawrence LSP; Chan RW; Chen H; Keller B; Stewart J; Ruschin M; Chugh B; Campbell M; Theriault A; Stanisz GJ; MacKenzie S; Myrehaug S; Detsky J; Maralani PJ; Tseng CL; Czarnota GJ; Sahgal A; Lau AZ
Radiother Oncol; 2021 Nov; 164():155-162. PubMed ID: 34592363
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of diffusion-weighted MRI and geometric distortion on a 0.35T MR-LINAC at multiple gantry angles.
Lewis B; Guta A; Mackey S; Gach HM; Mutic S; Green O; Kim T
J Appl Clin Med Phys; 2021 Feb; 22(2):118-125. PubMed ID: 33450146
[TBL] [Abstract][Full Text] [Related]
10. Accurate, repeatable, and geometrically precise diffusion-weighted imaging on a 0.35 T magnetic resonance imaging-guided linear accelerator.
Weygand J; Armstrong T; Bryant JM; Andreozzi JM; Oraiqat IM; Nichols S; Liveringhouse CL; Latifi K; Yamoah K; Costello JR; Frakes JM; Moros EG; El Naqa IM; Naghavi AO; Rosenberg SA; Redler G
Phys Imaging Radiat Oncol; 2023 Oct; 28():100505. PubMed ID: 38045642
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers.
McDonald BA; Salzillo T; Mulder S; Ahmed S; Dresner A; Preston K; He R; Christodouleas J; Mohamed ASR; Philippens M; van Houdt P; Thorwarth D; Wang J; Shukla Dave A; Boss M; Fuller CD
Radiother Oncol; 2023 Aug; 185():109717. PubMed ID: 37211282
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
[TBL] [Abstract][Full Text] [Related]
13. Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac.
Habrich J; Boeke S; Nachbar M; Nikolaou K; Schick F; Gani C; Zips D; Thorwarth D
Radiother Oncol; 2022 Sep; 174():141-148. PubMed ID: 35902042
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator.
Kooreman ES; van Houdt PJ; Nowee ME; van Pelt VWJ; Tijssen RHN; Paulson ES; Gurney-Champion OJ; Wang J; Koetsveld F; van Buuren LD; Ter Beek LC; van der Heide UA
Radiother Oncol; 2019 Apr; 133():156-162. PubMed ID: 30935572
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens.
Diaz de Leon A; Leyendecker JR; Otero-Muinelo S; Grewal H; Xi Y; Francis F; Pedrosa I; Costa DN
AJR Am J Roentgenol; 2018 Oct; 211(4):783-788. PubMed ID: 30160988
[TBL] [Abstract][Full Text] [Related]
16. Repeatability quantification of brain diffusion-weighted imaging for future clinical implementation at a low-field MR-linac.
Rabe M; Dietrich O; Forbrig R; Niyazi M; Belka C; Corradini S; Landry G; Kurz C
Radiat Oncol; 2024 Mar; 19(1):31. PubMed ID: 38448888
[TBL] [Abstract][Full Text] [Related]
17. Conventional vs. reduced field of view diffusion weighted imaging of the prostate: Comparison of image quality, correlation with histology, and inter-reader agreement.
Warndahl BA; Borisch EA; Kawashima A; Riederer SJ; Froemming AT
Magn Reson Imaging; 2018 Apr; 47():67-76. PubMed ID: 29103977
[TBL] [Abstract][Full Text] [Related]
18. ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium.
Kooreman ES; van Houdt PJ; Keesman R; Pos FJ; van Pelt VWJ; Nowee ME; Wetscherek A; Tijssen RHN; Philippens MEP; Thorwarth D; Wang J; Shukla-Dave A; Hall WA; Paulson ES; van der Heide UA
Radiother Oncol; 2020 Dec; 153():106-113. PubMed ID: 33017604
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
20. Is there a systematic bias of apparent diffusion coefficient (ADC) measurements of the breast if measured on different workstations? An inter- and intra-reader agreement study.
Clauser P; Marcon M; Maieron M; Zuiani C; Bazzocchi M; Baltzer PA
Eur Radiol; 2016 Jul; 26(7):2291-6. PubMed ID: 26443604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
